Outcome
| Type |
Measure |
Description |
Time frame |
Safety issue |
| Primary |
Mean Change from Baseline in Serum high-sensitivity C-reactive protein at 8 weeks |
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-6 at 8 weeks |
Interleukin (IL)-6 (pg/mL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-10 at 8 weeks |
Interleukin (IL)-10 (pg/mL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Monocyte chemoattractant protein-1 at 8 weeks |
Monocyte chemoattractant protein-1 (MCP-1; pg/mL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Tumor necrosis factor at 8 weeks |
Tumor necrosis factor (TNF)-alpha (pg/mL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Total Cholesterol at 8 weeks |
Total cholesterol (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in High-density lipoprotein (HDL)at 8 weeks |
High-density lipoprotein (HDL) (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Non-high-density lipoprotein (Non-HDL) at 8 weeks |
Non-high-density lipoprotein (Non-HDL) (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Low-density lipoprotein (LDL) at 8 weeks |
Low-density lipoprotein (LDL) (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Very-low-density lipoprotein (VLDL) at 8 weeks |
Very-low-density lipoprotein (VLDL) (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Triglycerides at 8 weeks |
Triglycerides (mg/dL). |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Total/HDL cholesterol at 8 weeks |
Total/HDL cholesterol (mg/dL) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Fasting blood glucose at 8 weeks |
Fasting blood glucose (mg/dL) |
Post-supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Oral glucose tolerance test (OGTT) at 8 weeks |
Oral glucose tolerance test (OGTT) (mg/dL). Following ingestion of 75 g oral glucose, blood samples will be drawn every 5-10 minutes for the first 30 minutes then every 30 minutes for the next 90 minutes. |
Post-supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Insulin at 8 weeks |
Insulin (µU/mL) |
Post-supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Total Body Fat Percentage at 8 weeks |
Total Body Fat Percentage (%BF): The percent of the body that is composed of fat. This will change based on the amount of fat there is as well as the amount of lean mass there is. |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Body weigh at 8 weeks |
Body weight (kilograms) |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Skeletal Muscle Mass Percentage at 8 weeks |
Skeletal Muscle Mass Percentage (%SMM): The percent of the body that is composed of skeletal muscle. Like %BF, this number is relative to total mass. |
Post-Supplementation at week 8 |
|
| Primary |
Mean Change from Baseline in Serum high-sensitivity C-reactive protein at 14 weeks |
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Monocyte chemoattractant protein-1 at 14 weeks |
Monocyte chemoattractant protein-1 (MCP-1; pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-6 at 14 weeks |
Interleukin (IL)-6 (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-10 at 14 weeks |
Interleukin (IL)-10 (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Tumor necrosis factor (TNF) at 14 weeks |
Tumor necrosis factor (TNF)-alpha (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Total Cholesterol at 14 weeks |
Total Cholesterol (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in High-density lipoprotein (HDL) at 14 weeks |
High-density lipoprotein (HDL) (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Non-high-density lipoprotein (Non-HDL) at 14 weeks |
Non-high-density lipoprotein (Non-HDL) (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Low-density lipoprotein (LDL) at 14 weeks |
Low-density lipoprotein (LDL) (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Very-low-density lipoprotein (VLDL) at 14 weeks |
Very-low-density lipoprotein (VLDL) (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Triglycerides at 14 weeks |
Triglycerides (mg/dL). |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in total/HDL cholesterol at 14 weeks |
Total/HDL cholesterol (mg/dL) |
Post-intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Fasting blood glucose at 14 weeks |
Fasting blood glucose (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Oral glucose tolerance test (OGTT) at 14 weeks |
Oral glucose tolerance test (OGTT). Following ingestion of 75 g oral glucose, blood samples will be drawn every 5-10 minutes for the first 30 minutes then every 30 minutes for the next 90 minutes. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Insulin at 14 weeks |
Insulin (µU/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Body weight at 14 weeks |
Body weight (kilograms) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Total Body Fat Percentage at 14 weeks |
Total Body Fat Percentage (%BF): The percent of the body that is composed of fat. This will change based on the amount of fat there is as well as the amount of lean mass there is. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Skeletal Muscle Mass Percentage at 14 weeks |
Skeletal Muscle Mass Percentage (%SMM): The percent of the body that is composed of skeletal muscle. Like %BF, this number is relative to total mass. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Baseline in Serum high-sensitivity C-reactive protein at 16 weeks |
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-6 at 16 weeks |
Interleukin (IL)-6 (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Interleukin (IL)-10 at 16 weeks |
Interleukin (IL)-10 (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Tumor necrosis factor (TNF) at 16 weeks |
Tumor necrosis factor (TNF)-alpha (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Monocyte chemoattractant protein-1 at 16 weeks |
Monocyte chemoattractant protein-1 (MCP-1; pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Total Cholesterol at 16 weeks |
Total Cholesterol (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in High-density lipoprotein (HDL) at 16 weeks |
High-density lipoprotein (HDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Non-high-density lipoprotein (Non-HDL) at 16 weeks |
Non-high-density lipoprotein (Non-HDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Low-density lipoprotein (LDL) at 16 weeks |
Low-density lipoprotein (LDL)(mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Very-low-density lipoprotein (VLDL) at 16 weeks |
Very-low-density lipoprotein (VLDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Total/HDL cholesterol at 16 weeks |
Total/HDL cholesterol (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Triglycerides at 16 weeks |
Triglycerides (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Insulin at 16 weeks |
Insulin (µU/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Fasting blood glucose at 16 weeks |
Fasting blood glucose (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Oral glucose tolerance test (OGTT) at 16 weeks |
Oral glucose tolerance test (OGTT). Following ingestion of 75 g oral glucose, blood samples will be drawn every 5-10 minutes for the first 30 minutes then every 30 minutes for the next 90 minutes. |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Skeletal Muscle Mass Percentage at 16 weeks |
Skeletal Muscle Mass Percentage (%SMM): The percent of the body that is composed of skeletal muscle. Like %BF, this number is relative to total mass. |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Body weight at 16 weeks |
Body weight (kilograms) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Baseline in Total Body Fat Percentage at 16 weeks |
Total Body Fat Percentage (%BF): The percent of the body that is composed of fat. This will change based on the amount of fat there is as well as the amount of lean mass there is. |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Supplementation in Serum high-sensitivity C-reactive protein at 14 weeks |
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Interleukin (IL)-6 at 14 weeks |
Interleukin (IL)-6 (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Interleukin (IL)-10 at 14 weeks |
Interleukin (IL)-10 (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Monocyte chemoattractant protein-1 at 14 weeks |
Monocyte chemoattractant protein-1 (MCP-1; pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Tumor necrosis factor (TNF) at 14 weeks |
Tumor necrosis factor (TNF)-alpha (pg/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Total Cholesterol at 14 weeks |
Total Cholesterol (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Total/HDL cholesterol at 14 weeks |
Total/HDL cholesterol (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in High-density lipoprotein (HDL) at 14 weeks |
High-density lipoprotein (HDL) (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Non-high-density lipoprotein (Non-HDL) at 14 weeks |
Non-high-density lipoprotein (Non-HDL) (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Low-density lipoprotein (LDL) at 14 weeks |
Low-density lipoprotein (LDL) (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Very-low-density lipoprotein (VLDL) at 14 weeks |
Very-low-density lipoprotein (VLDL) (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Triglycerides at 14 weeks |
Triglycerides (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Insulin at 14 weeks |
Insulin (µU/mL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Oral glucose tolerance test (OGTT) at 14 weeks |
Oral glucose tolerance test (OGTT) Following ingestion of 75 g oral glucose, blood samples will be drawn every 5-10 minutes for the first 30 minutes then every 30 minutes for the next 90 minutes. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Fasting blood glucose at 14 weeks |
Fasting blood glucose (mg/dL) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Body weight at 14 weeks |
Body weight (kilograms) |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Total Body Fat Percentage at 14 weeks |
Total Body Fat Percentage (%BF): The percent of the body that is composed of fat. This will change based on the amount of fat there is as well as the amount of lean mass there is. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Supplementation in Skeletal Muscle Mass Percentage at 14 weeks |
Skeletal Muscle Mass Percentage (%SMM): The percent of the body that is composed of skeletal muscle. Like %BF, this number is relative to total mass. |
Post-Intervention at week 14 |
|
| Primary |
Mean Change from Post-Intervention in Serum high-sensitivity C-reactive protein at 16 weeks |
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Tumor Necrosis Factor (TNF) at 16 weeks |
Tumor necrosis factor (TNF)-alpha (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Interleukin (IL)-6 at 16 weeks |
Interleukin (IL)-6 (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Interleukin (IL)-10 at 16 weeks |
Interleukin (IL)-10 (pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Monocyte Chemoattractant Protein-1 at 16 weeks |
Monocyte chemoattractant protein-1 (MCP-1; pg/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Total Cholesterol at 16 weeks |
Total Cholesterol (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in High-density lipoprotein (HDL) at 16 weeks |
High-density lipoprotein (HDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Non-high-density lipoprotein (Non-HDL) at 16 weeks |
Non-high-density lipoprotein (Non-HDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Low-density lipoprotein (LDL) at 16 weeks |
Low-density lipoprotein (LDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Very-low-density lipoprotein (VLDL) at 16 weeks |
Very-low-density lipoprotein (VLDL) (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Total/HDL cholesterol at 16 weeks |
Total/HDL cholesterol (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Triglycerides at 16 weeks |
Triglycerides (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Insulin at 16 weeks |
Insulin (µU/mL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Fasting blood glucose at 16 weeks |
Fasting blood glucose (mg/dL) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Oral glucose tolerance test (OGTT) at 16 weeks |
Oral glucose tolerance test (OGTT). Following ingestion of 75 g oral glucose, blood samples will be drawn every 5-10 minutes for the first 30 minutes then every 30 minutes for the next 90 minutes. |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Body weight at 16 weeks |
Body weight (kilograms) |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Total Body Fat Percentage at 16 weeks |
Total Body Fat Percentage (%BF): The percent of the body that is composed of fat. This will change based on the amount of fat there is as well as the amount of lean mass there is. |
Post-Feeding at week 16 |
|
| Primary |
Mean Change from Post-Intervention in Skeletal Muscle Mass Percentage at 16 weeks |
Skeletal Muscle Mass Percentage (%SMM): The percent of the body that is composed of skeletal muscle. Like %BF, this number is relative to total mass. |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Bacterial Profile at 8 weeks |
Fecal Microbial DNA (16s Sequencing) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Serum Acetate Profile at 8 weeks |
Serum Acetate (SCFA: gas chromatography analysis) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Fecal acetate Profile at 8 weeks |
Fecal acetate (SCFA: in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Propionate Profile at 8 weeks |
Propionate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Butyrate Profile at 8 weeks |
Butyrate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides at 8 weeks |
Serum lipopolysaccharides (LPS, ng/ml) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides-binding protein at 8 weeks |
Serum lipopolysaccharides-binding protein (LBP, pg/ml) |
Post-Supplementation at week 8 |
|
| Secondary |
Mean Change from Baseline in Bacterial Profile at 14 weeks |
Fecal Microbial DNA (16s Sequencing) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Serum Acetate Profile at 14 weeks |
Serum Acetate (SCFA: gas chromatography analysis) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Fecal acetate Profile at 14 weeks |
Fecal acetate (SCFA: in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Propionate Profile at 14 weeks |
Propionate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Butyrate Profile at 14 weeks |
Butyrate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides at 14 weeks |
Serum lipopolysaccharides (LPS, ng/ml) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides-binding protein at 14 weeks |
Serum lipopolysaccharides-binding protein (LBP, pg/ml) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Baseline in Serum Acetate Profile at 16 weeks |
Serum Acetate (SCFA: gas chromatography analysis) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Fecal acetate Profile at 16 weeks |
Fecal acetate (SCFA: in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Bacterial Profile at 16 weeks |
Fecal Microbial DNA (16s Sequencing) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Propionate Profile at 16 weeks |
Propionate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Butyrate Profile at 16 weeks |
Butyrate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides at 16 weeks |
Serum lipopolysaccharides (LPS, ng/ml) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Baseline in Markers of Serum lipopolysaccharides-binding protein at 16 weeks |
Serum lipopolysaccharides-binding protein (LBP, pg/ml) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Supplementation in Bacterial Profile at 14 weeks |
Fecal Microbial DNA (16s Sequencing) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Serum Acetate Profile at 14 weeks |
Serum Acetate (SCFA: gas chromatography analysis) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Fecal acetate Profile at 14 weeks |
Fecal acetate (SCFA: in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Propionate Profile at 14 weeks |
Propionate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Butyrate Profile at 14 weeks |
Butyrate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Markers of Serum lipopolysaccharides at 14 weeks |
Serum lipopolysaccharides (LPS, ng/ml) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Supplementation in Markers of Serum lipopolysaccharides-binding protein at 14 weeks |
Serum lipopolysaccharides-binding protein (LBP, pg/ml) |
Post-Intervention at week 14 |
|
| Secondary |
Mean Change from Post-Intervention in Bacterial Profile at 16 weeks |
Fecal Microbial DNA (16s Sequencing) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Serum Acetate Profile at 16 weeks |
Serum Acetate (SCFA: gas chromatography analysis) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Fecal acetate Profile at 16 weeks |
Fecal acetate (SCFA: in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Propionate Profile at 16 weeks |
Propionate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Butyrate Profile at 16 weeks |
Butyrate (liquid chromatography tandem mass spectrometry (LC-MS/MS)) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Markers of Serum lipopolysaccharides at 16 weeks |
Serum lipopolysaccharides (LPS, ng/ml) |
Post-Feeding at week 16 |
|
| Secondary |
Mean Change from Post-Intervention in Markers of Serum lipopolysaccharides-binding protein at 16 weeks |
Serum lipopolysaccharides-binding protein (LBP, pg/ml) |
Post-Feeding at week 16 |
|
